Skip to content
10-Q

Quarterly Report

AETERNUM HEALTH, INC. AETN

0001493152-24-045717

← back to feed
Filed
Nov 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 12, 2024 48.48M sh
Cash And Equivalents Q3 2024 · Sep 30, 2024 $0
Cash And Equivalents Q3 2024 · Dec 31, 2021 $0
Current Liabilities Q3 2024 · Sep 30, 2024 $690.06K
Current Liabilities Q3 2024 · Dec 31, 2023 $501.28K
Total Liabilities Q3 2024 · Sep 30, 2024 $1.61M
Total Liabilities Q3 2024 · Dec 31, 2023 $1.53M
Current Assets Q3 2024 · Sep 30, 2024 $72.03K
Current Assets Q3 2024 · Dec 31, 2023 $307.5K
Total Assets Q3 2024 · Sep 30, 2024 $73.03K
Total Assets Q3 2024 · Dec 31, 2023 $308.5K
Cost Of Revenue Q3 2024 · Sep 30, 2024 $28.9K
Cost Of Revenue Q3 2024 · Sep 30, 2024 $59.25K
Cost Of Revenue Q3 2024 · Sep 30, 2023 $17.37K
Cost Of Revenue Q3 2024 · Sep 30, 2023 $50.55K
Shares Diluted Q3 2024 · Sep 30, 2023 47.79M sh
Shares Diluted Q3 2024 · Sep 30, 2023 40.46M sh
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$122.49K
Stockholders Equity Q3 2024 · Sep 30, 2023 −$1.14M
Stockholders Equity Q3 2024 · Jun 30, 2023 −$1.19M
Stockholders Equity Q3 2024 · Mar 31, 2023 −$892.26K
Stockholders Equity Q3 2024 · Dec 31, 2022 −$1.45M
Eps Diluted Q3 2024 · Sep 30, 2023 $0.00
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.01
Eps Basic Q3 2024 · Sep 30, 2023 $0.00
Eps Basic Q3 2024 · Sep 30, 2023 −$0.01
Sga Expense Q3 2024 · Sep 30, 2023 $34.29K
Sga Expense Q3 2024 · Sep 30, 2023 $285.46K
Net Income Q3 2024 · Sep 30, 2023 −$141.02K
Net Income Q3 2024 · Sep 30, 2023 −$544.58K
Net Income Q3 2024 · Jun 30, 2023 −$301.9K
Net Income Q3 2024 · Mar 31, 2023 −$101.66K
Operating Income Q3 2024 · Sep 30, 2023 −$110.56K
Operating Income Q3 2024 · Sep 30, 2023 −$483.09K
Gross Profit Q3 2024 · Sep 30, 2023 −$15.87K
Gross Profit Q3 2024 · Sep 30, 2023 −$35.64K
Revenue Q3 2024 · Sep 30, 2023 $3.68K
Revenue Q3 2024 · Sep 30, 2023 $19.85K